Compare · MGRX vs SHC
MGRX vs SHC
Side-by-side comparison of Mangoceuticals Inc. (MGRX) and Sotera Health Company (SHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MGRX and SHC operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- SHC is the larger of the two at $5.16B, about 722.8x MGRX ($7.1M).
- MGRX has been more active in the news (8 items in the past 4 weeks vs 2 for SHC).
- SHC has more recent analyst coverage (25 ratings vs 0 for MGRX).
- Company
- Mangoceuticals Inc.
- Sotera Health Company
- Price
- -
- -
- Market cap
- $7.1M
- $5.16B
- 1M return
- -
- -5.57%
- 1Y return
- -
- +10.80%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2020
- News (4w)
- 8
- 2
- Recent ratings
- 0
- 25
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Latest MGRX
- SEC Form 8-K filed by Mangoceuticals Inc.
- SEC Form 424B5 filed by Mangoceuticals Inc.
- Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
- SEC Form 4 filed by Mangoceuticals Inc.
- SEC Form 4 filed by Mangoceuticals Inc.
- SEC Form 4 filed by Mangoceuticals Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Mangoceuticals Inc.
- Mangoceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Regulation FD Disclosure
- Mangoceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form 10-Q filed by Mangoceuticals Inc.
Latest SHC
- Sotera Health downgraded by Analyst with a new price target
- Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company
- Executive Chairman Petras Michael B. Jr. sold $21,174,786 worth of shares (1,144,515 units at $18.50), decreasing direct ownership by 43% to 397,912 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company
- Sotera Health Company filed SEC Form 8-K: Leadership Update
- President of Sterigenics Rutz Michael P sold $2,825,250 worth of shares (150,000 units at $18.84), decreasing direct ownership by 31% to 334,279 units (SEC Form 4)
- Sr. Vice President, CFO Lyons Jonathan M. covered exercise/tax liability with 11,316 shares, decreasing direct ownership by 5% to 217,304 units (SEC Form 4) (tax liability)
- SEC Form 144 filed by Sotera Health Company
- SEC Form 10-Q filed by Sotera Health Company
- Sotera Health Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits